EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ten‐year clinical outcomes after drug‐eluting stents implantation according to clinical presentation—Insights from the DECADE cooperation

Fabian Starnecker iD, J J Coughlan, Lisette Okkels Jensen, Sarah Bär, Sebastian Kufner, Salvatore Brugaletta, Lorenz Räber, Michael Maeng, Luis Ortega-Paz, Dik Heg, Karl-Ludwig Laugwitz, Manel Sabaté und 4 weitere

European Journal of Clinical Investigation · 2025-01 · 55 (1)

DOI: 10.1111/eci.14323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2024-10. Verfasst von Fabian Starnecker und 15 weiteren Autor:innen. Beteiligte Einrichtung: Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Myocardial Infarction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Investigations of very long‐term outcomes after percutaneous coronary intervention (PCI) with drug‐eluting stents (DES) according to clinical presentation are scarce. Here, we investigated the 10‐year clinical outcomes of patients undergoing DES‐PCI according to clinical presentation.

Methods

Patient‐level data from five randomized trials with 10‐year follow‐up after DES‐PCI were pooled. Patients were dichotomized into acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) groups as per clinical presentation. The primary outcome was all‐cause death. Secondary outcomes were cardiovascular death, myocardial infarction (MI), definite stent thrombosis (ST) and repeat revascularization involving the target lesion (TLR), target vessel (TVR) or non‐target vessel (nTVR).

Results

Of the 9700 patients included in this analysis, 4557 presented with ACS and 5143 with CCS. Compared with CCS patients, ACS patients had a higher risk of all‐cause death and nTVR in the first year, but comparable risk thereafter. In addition, ACS patients had a higher risk of MI [adjusted hazard ratio 1.21, 95% confidence interval (1.04–1.41)] and definite ST [adjusted hazard ratio 1.48, 95% confidence interval (1.14–1.92)], while the risk of TLR and TVR was not significantly different up to 10‐year follow‐up.

Conclusions

Compared to CCS patients, ACS patients treated with PCI and DES implantation have an increased risk of all‐cause death and repeat revascularization of remote vessels up to 1 year, with no significant differences thereafter and up to 10‐year follow‐up. ACS patients have a consistently higher risk of MI and definite ST. Whether these differences persist with current antithrombotic and secondary prevention therapies requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsPercutaneous Coronary InterventionAcute Coronary SyndromeMyocardial InfarctionHumansMaleFemaleMiddle AgedAgedTreatment OutcomeCause of DeathRandomized Controlled Trials as TopicMortality

Stichwörter der Autor:innen

NSTE‐ACSSTEMIacute coronary syndromechronic coronary syndromedrug‐eluting stentspercutaneous coronary intervention

Autor:innen und Institutionen

  • Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
  • Cardiovascular Research Institute, Mater Private Network, Dublin, Ireland.
  • Department of Cardiology, Odense University Hospital, Odense, Denmark.
  • Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.

ORCID-Profile: Fabian Starnecker, Kevin Kris Warnakula Olesen

Zitieren

APA

Starnecker, F., Coughlan, J. J., Jensen, L. O., Bär, S., Kufner, S., Brugaletta, S., Räber, L., Maeng, M., Ortega-Paz, L., Heg, D., Laugwitz, K. L., Sabaté, M., Windecker, S., Kastrati, A., Olesen, K. K. W., & Cassese, S. (2025). Ten‐year clinical outcomes after drug‐eluting stents implantation according to clinical presentation—Insights from the DECADE cooperation. European Journal of Clinical Investigation, 55(1). https://doi.org/10.1111/eci.14323

Vancouver

Starnecker F, Coughlan JJ, Jensen LO, Bär S, Kufner S, Brugaletta S, et al. Ten‐year clinical outcomes after drug‐eluting stents implantation according to clinical presentation—Insights from the DECADE cooperation. European Journal of Clinical Investigation. 2025;55(1). doi:10.1111/eci.14323

BibTeX
@article{Starnecker2025,
  author = {Starnecker, Fabian and Coughlan, J J and Jensen, Lisette Okkels and Bär, Sarah and Kufner, Sebastian and Brugaletta, Salvatore and Räber, Lorenz and Maeng, Michael and Ortega-Paz, Luis and Heg, Dik and Laugwitz, Karl-Ludwig and Sabaté, Manel and Windecker, Stephan and Kastrati, Adnan and Olesen, Kevin Kris Warnakula and Cassese, Salvatore},
  title = {Ten‐year clinical outcomes after drug‐eluting stents implantation according to clinical presentation—Insights from the DECADE cooperation},
  journal = {European Journal of Clinical Investigation},
  year = {2025},
  volume = {55},
  number = {1},
  doi = {10.1111/eci.14323}
}
Kostenlos starten →